50 likes | 60 Views
Discover NEUCA Group's remarkable achievements in 2011, with a 38% increase in net profit totaling 1.5BN EUR and revenues reaching 12.75M EUR. Explore our diverse range of 17,000 products, expanding market share, and workforce of 9,000, including 2/3 women. With 3,300 pharmacies involved in partnership programs, NEUCA remains a key player in Poland's healthcare market. Learn about our strategic milestones, including the establishment of TORFARM and our role as a distribution market leader.
E N D
NEUCA GROUP March 2012
NEUCA in numbers 38% Increasein net profit for 2011 1,5BN EUR Revenuesin 2011 12,75 M EUR Net profit in 2011 17 000 Offered products 30,5% Market share 3 500 Ourworkforce, 2/3 of itwomen 9 000 Pharmaciesreceivingour products 3 300 Pharmaciesparticipatinginpartnershipprograms 300 000 24 houroutputcapacity of Ołtarzew warehouse
NEUCA’s history milestones Establishment of a holding company NEUCA and business optimisation Establishment of a family-owned company: TORFARM 2001/2004 1990 30,5% share inPolish distributionmarket in 2011 Increasing market share through organic growth
Group structure Holding company: Group management Wholesale operations Healthcare market services Wholesale activity Own pharmaceuticals Reader club Shared Service Centre and IT Centre
Leader in the distribution of pharmaceuticals Value of Polish market of pharmaceutical distribution(bn EUR) Market share of main players on the Polish distribution market in 2011 14 205pharmacies in 2011 Based on average PLN = EURexchange rate for the period Source: Own estimations NEUCA Group shares include AstraZeneca product sale (system of direct sale ) • NEUCA has the widest range of numeric distribution in Poland: • 9000 pharmacies 1.200.000clients daily on avg. • 150sales representatives • 700 Telemarketers